LoadingJANUS HENDERSON INVESTORS US LLC reported Sale in Privacore PCAAM Alternative Income Fund: 176400 units of Class I Shares, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
NMRK
Itzkowitz Jay reported 3,524 shares of Class A Common Stock, par value $0.01 per share in NEWMARK GROUP, INC. as grants or awards dated 2026-09-16. The Form 4 was disclosed on Sep 17, 2026. These were stock awards, not open-market purchases.
H
Travis Tracey Thomas reported 156 shares of Class A Common Stock in Hyatt Hotels Corp as grants or awards dated 2026-09-15. The Form 4 was disclosed on Sep 17, 2026. These were stock awards, not open-market purchases.
H
Pritzker Jason reported Grant or award in Hyatt Hotels Corp: 156 units of Restricted Stock Units (derivative), dated 2026-09-15. The full Form 4 contains 1 transaction entry.
VERA
Fordyce Marshall reported Exercise or conversion in Vera Therapeutics, Inc.: 18500 units of Class A Common Stock, dated 2026-09-15. The full Form 4 contains 3 transaction entries.
FTAI
ROBINSON RAY M reported Grant or award in FTAI Aviation Ltd.: 164 units of Ordinary Shares, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
FTAI
GIDUMAL SHYAM H reported Grant or award in FTAI Aviation Ltd.: 125 units of Ordinary Shares, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
OFG
FERNANDEZ JOSE RAFAEL reported Gift in OFG BANCORP: 10000 units of Common Stock, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
CRAFX
Nesbitt Stephen Lane reported Purchase in Cascade Real Assets Fund: 500000.000 units of Class I Shares, dated 2026-09-21. The full Form 4 contains 1 transaction entry.
PNRG
FONG GIFFORD reported Purchase in PRIMEENERGY RESOURCES CORP: 100 units of COMMON STOCK, dated 2026-09-18. The full Form 4 contains 1 transaction entry.
LEDR
Shukla Chinmay reported Other (see filing) in Leader's Advantage Acquisition Corp.: 15000 units of Class B Ordinary Shares (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
LEDR
Chakrabarti Paritosh M.; Leader's Advantage Company, LLC reported Other (see filing) in Leader's Advantage Acquisition Corp.: 95000 units of Class B Ordinary Shares (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
CV
HARARI ELIYAHOU ET AL reported Purchase in CapsoVision, Inc: 878735 units of Common Stock, dated 2026-09-18. The full Form 4 contains 2 transaction entries.
NWCL
Rizzotti Elisabeth reported Grant or award in newcleo plc: 96140 units of Stock Options (Right to Buy) (derivative), dated 2026-09-21. The full Form 4 contains 5 transaction entries.
LEDR
Ang Andrew reported Other (see filing) in Leader's Advantage Acquisition Corp.: 15000 units of Class B Ordinary Shares (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
GCT
Bernes Marshall reported Sale in GigaCloud Technology Inc: 12000 units of Class A Ordinary Shares, par value $0.05 per share, dated 2026-09-21. The full Form 4 contains 2 transaction entries.
LEDR
Constantinides George Michael reported Other (see filing) in Leader's Advantage Acquisition Corp.: 15000 units of Class B Ordinary Shares (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
LEDR
Krynski Edward reported Other (see filing) in Leader's Advantage Acquisition Corp.: 15000 units of Class B Ordinary Shares (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
LEDR
Chakrabarti Raj reported Other (see filing) in Leader's Advantage Acquisition Corp.: 25000 units of Class B Ordinary Shares (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
NWCL
Buono Stefano reported Grant or award in newcleo plc: 134596 units of Stock Options (Right to Buy) (derivative), dated 2026-09-21. The full Form 4 contains 5 transaction entries.
BPRE
KAMFAR RAMIN reported Other (see filing) in Bluerock Private Real Estate Fund: 67878 units of Common Shares of Beneficial Interest, dated 2026-09-21. The full Form 4 contains 4 transaction entries.
ABUS
Beardsley Robert A reported Exercise or conversion in Arbutus Biopharma Corp: 52533 units of Common Shares, dated 2026-09-18. The full Form 4 contains 5 transaction entries.
ABUS
Sawhney Roger reported Exercise or conversion in Arbutus Biopharma Corp: 52533 units of Common Shares, dated 2026-09-18. The full Form 4 contains 5 transaction entries.
ABUS
Nguyen Tuan reported Exercise or conversion in Arbutus Biopharma Corp: 265625 units of Common Shares, dated 2026-09-18. The full Form 4 contains 5 transaction entries.
